Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Revvity | PKI - Aktiva
Keuangan
Harga Saham
USD 152.64
Aktiva
USD 12.05B
Kas Dan Setara
USD 1.02B
Biaya Penjualan
USD 312.82M
Aset Lancar
USD 2.3B
Kewajiban Lancar
USD 1.28B
UTANG
USD 3.35B
Dividen - Hasil
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
Karyawan
11K
Eps Laba Per Saham
USD 1.41
Modal Dan Cadangan
USD 7.18B
Laba Kotor Pada Penjualan
USD 416.87M
Beban Bunga Utang
USD 22.99M
Pendapatan Bunga
USD 6.3M
Modal Pinjaman
USD 2.63B
Kapitalisasi Pasar
USD 19.09B
Batas Pemasukan
USD 51.82M
Biaya Operasional
USD 603.55M
Laba Operasional
USD 126.14M
Modal Saham Biasa
USD 111.63M
Pe Harga Untuk Laba
36.47
Laba Sebelum Pajak
USD 187.24M
Pendapatan Penjualan
USD 729.68M
Beban Penjualan Dan Administrasi
USD 278.58M
Saham
USD 378.5M
Kreditur Perdagangan
USD 165.74M
Debitur Perdagangan
USD 709.18M
Aktiva
Perubahan
Tanggal
Agilent
USD 13.97B
902M
2026-06
Align Technology
USD 6.42B
103.41M
2026-06
Bio Techne
USD 2.59B
36.12M
2026-06
Bio-Rad Laboratories
USD 10.25B
462M
2026-06
Bruker
USD 6.05B
77.8M
2026-06
Celltrion
KRW 768.81B
9.37B
2026-03
Charles River Laboratories
USD 7.53B
198.16M
2026-06
Cspc Pharmaceutical
CNY 46.7B
695.56M
2025-12
Danaher
USD 92.37B
8.82B
2026-06
Dentsply International
USD 5.2B
25M
2026-06
Deva Holding AS
TRY 12.93B
1.83B
2023-09
Dianthus Therapeutics
USD 1.21B
33.61M
2026-06
Divis Laboratories Ltd
INR 200.33B
18.82B
2026-03
Edwards Lifesciences
USD 13.87B
545.9M
2026-06
Illumina
USD 6.65B
91M
2026-06
Intuitive Surgical
USD 20.88B
765.6M
2026-06
IQVIA Holdings
USD 29.88B
206M
2026-06
Kangmei Pharma
CNY 13.07B
239.31M
2026-06
Knight Therapeutics
CAD 1.05B
2.28M
2025-12
Laboratorios Farma
EUR 799.88M
99.95M
2023-12
Laboratory Of America
USD 18.53B
554.8M
2026-06
Malin Corporation
EUR 198.5M
70.1M
2024-12
Medical Developments International
AUD 63.57M
2.83M
2025-12
Mesa Laboratories
USD 434.85M
4.5M
2025-12
Mettler Toledo International
USD 3.67B
2.03M
2026-06
Myriad Genetics
USD 638.9M
34.8M
2026-06
Neuren Pharmaceuticals
AUD 342.86M
11.61M
2025-12
OraSure Technologies
USD 360.55M
18.62M
2026-06
Organigram Holdings
CAD 521.31M
9.36M
2026-03
Ovoca Bio
EUR 2.07M
414K
2025-12
Pacific Biosciences Of California
USD 751.85M
30.51M
2026-06
Pharma Mar
EUR 393.6M
8.34M
2026-06
Qiagen NV
USD 5.89B
107.14M
2026-06
Quest Diagnostics
USD 16.94B
266M
2026-06
Quidel
USD 5.72B
86.6M
2026-06
Repligen
USD 2.95B
19.41M
2026-06
Revvity
USD 12.05B
49.24M
2026-06
Sartorius
EUR 9.6B
270.6M
2026-06
Sino Biopharmaceutical
CNY 74.89B
9.49B
2025-06
Thermo Fisher Scientific
USD 113.17B
107M
2026-06
Tilray
USD 2.1B
15.95M
2025-09
Waters
USD 24.75B
220M
2026-06
Zealand Pharma A/S
15.3B
647.8M
2026-03
Zz Pientze Pharmaceu
CNY 18.51B
129.02M
2026-06
×